Protagonist Therapeutics, Inc Quarterly Return On Equity in % from Q1 2017 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Protagonist Therapeutics, Inc quarterly/annual Return On Equity history and growth rate from Q1 2017 to Q3 2024.
  • Protagonist Therapeutics, Inc Return On Equity for the quarter ending September 30, 2024 was 34.7 %.
  • Protagonist Therapeutics, Inc annual Return On Equity for 2023 was -27.5 %, a 44.5% increase from 2022.
  • Protagonist Therapeutics, Inc annual Return On Equity for 2022 was -49.5 %, a 22.9% decline from 2021.
  • Protagonist Therapeutics, Inc annual Return On Equity for 2021 was -40.3 %, a 3.44% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 34.7 +89.4 Jul 1, 2024 Sep 30, 2024
Q2 2024 39.1 +95.8 Apr 1, 2024 Jun 30, 2024
Q1 2024 43.4 +103 Jan 1, 2024 Mar 31, 2024
Q4 2023 -27.5 +22 +44.5% Oct 1, 2023 Dec 31, 2023
Q3 2023 -54.7 -7.92 -16.9% Jul 1, 2023 Sep 30, 2023
Q2 2023 -56.8 -12.5 -28.3% Apr 1, 2023 Jun 30, 2023
Q1 2023 -59.4 -21.4 -56.4% Jan 1, 2023 Mar 31, 2023
Q4 2022 -49.5 -9.23 -22.9% Oct 1, 2022 Dec 31, 2022
Q3 2022 -46.7 -11.7 -33.2% Jul 1, 2022 Sep 30, 2022
Q2 2022 -44.3 -13.7 -44.7% Apr 1, 2022 Jun 30, 2022
Q1 2022 -38 -6.02 -18.8% Jan 1, 2022 Mar 31, 2022
Q4 2021 -40.3 -1.34 -3.44% Oct 1, 2021 Dec 31, 2021
Q3 2021 -35.1 +18.9 +35% Jul 1, 2021 Sep 30, 2021
Q2 2021 -30.6 +41.8 +57.8% Apr 1, 2021 Jun 30, 2021
Q1 2021 -32 +71.2 +69% Jan 1, 2021 Mar 31, 2021
Q4 2020 -39 +46.7 +54.5% Oct 1, 2020 Dec 31, 2020
Q3 2020 -54 +20.9 +27.9% Jul 1, 2020 Sep 30, 2020
Q2 2020 -72.4 -9.92 -15.9% Apr 1, 2020 Jun 30, 2020
Q1 2020 -103 -62.4 -153% Jan 1, 2020 Mar 31, 2020
Q4 2019 -85.7 -51.7 -152% Oct 1, 2019 Dec 31, 2019
Q3 2019 -74.9 -50.8 -211% Jul 1, 2019 Sep 30, 2019
Q2 2019 -62.5 -38.3 -159% Apr 1, 2019 Jun 30, 2019
Q1 2019 -40.8 -6.31 -18.3% Jan 1, 2019 Mar 31, 2019
Q4 2018 -33.9 +13.1 +27.8% Oct 1, 2018 Dec 31, 2018
Q3 2018 -24.1 +40.1 +62.5% Jul 1, 2018 Sep 30, 2018
Q2 2018 -24.2 +34.9 +59.1% Apr 1, 2018 Jun 30, 2018
Q1 2018 -34.5 +39.5 +53.4% Jan 1, 2018 Mar 31, 2018
Q4 2017 -47 Oct 1, 2017 Dec 31, 2017
Q3 2017 -64.2 Jul 1, 2017 Sep 30, 2017
Q2 2017 -59.1 Apr 1, 2017 Jun 30, 2017
Q1 2017 -74 Jan 1, 2017 Mar 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.